Obesity contributes to the development and progression of Type 2 diabetes, a disease characterized by high blood sugar levels, insulin resistance, and a relative lack of insulin
Obesity, hypertriglyceridemia, and metabolic syndromeconditions commonly present in patients prescribed GLP-1 agonistsare themselves established risk factors for pancreatic inflammation
Several barriers must be overcome when developing orally administered peptides with a molecular weight above 1,000 Da, including enzymatic degradation in the GI tract, pH-induced conformational changes, limited permeability of the intestinal membrane, and variable GI tract absorption rates [2, 3, 42, 43]
Mashayekhi, M., Nian, H., Mayfield, D., Devin, J
This method ensures that the bodys internal stores in the liver are replenished without the need for a daily procedure
One caveat the literature is honest about: as of May 2026, no randomized controlled trial has yet tested resistance training as a counter-measure specifically to GLP-1-induced lean-mass loss